Treatment of human disease by adeno-associated viral gene transfer. - Wikidata - awgldk - TriplyDB

Treatment of human disease by adeno-associated viral gene transfer.

Treatment of human disease by adeno-associated viral gene transfer.

http://www.wikidata.org/entity/Q36448393

about

Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options Tissue engineering for bone regeneration and osseointegration in the oral cavity Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome.Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues.Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin.Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9.Harnessing the Potential of Human Pluripotent Stem Cells and Gene Editing for the Treatment of Retinal Degeneration.Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging.Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery.Characterization of naturally-occurring humoral immunity to AAV in sheep.Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector Analyzing cellular immunity to AAV in a canine model using ELISPOT assay Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes Gene therapy approaches for lysosomal storage disease: next-generation treatment.Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales.Pseudotyped adeno-associated virus 2/9-delivered CCL11 shRNA alleviates lung inflammation in an allergen-sensitized mouse model.Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.Two decades of clinical gene therapy--success is finally mounting Surface loop dynamics in adeno-associated virus capsid assembly.Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses Gene therapy for viral hepatitis.Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.Manufacturing and characterizing AAV-based vectors for use in clinical studies.A small regulatory element from chromosome 19 enhances liver-specific gene expression.The Jeremiah Metzger Lecture: gene therapy for inherited disorders: from Christmas disease to Leber's amaurosis.Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide Functional promoter testing using a modified lentiviral transfer vector Gene therapy in large animal models of muscular dystrophy.Transient transfection methods for clinical adeno-associated viral vector production.Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype.AAV-directed muscular dystrophy gene therapy.Immunotherapeutic polyoma and human papilloma virus-like particles.Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes.Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications.Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats.Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responses.Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo.

P2860

Q28075612-43962C4C-6085-47FC-8024-4F053CB3F73B Q28087194-7B61078B-8B4B-432B-8698-4FD79774949E Q30490193-F26B6779-73E1-45D9-BBD6-2F52F6DDD723 Q30505116-63CDE677-5AB1-4927-BD0A-74C5FE86B92A Q33307618-AD3D9752-8E91-4504-BA88-90F85407467B Q33713259-890F5DB2-9F78-4AB4-98F4-59C46F1F6A56 Q33729610-3ED9EC8B-1F22-44DB-9DD2-40DBF29C77F3 Q33731159-C2B29B52-E07A-4E7A-B0ED-BE8A8A43072A Q34059643-450A6855-732B-4AC2-A33B-5567131B64F4 Q34211507-3BC25E7A-1037-4D6C-9BD5-5A73A1C7433C Q34653703-6267BE68-8BC8-477A-AA47-9DAD7A49AD92 Q35005408-2ED2C39B-0FAE-432E-9412-0A2A0D601FF4 Q35513407-3F739E7B-9868-49B9-AD1E-EEC64B365014 Q35892390-BE4B1B97-B72F-490A-82EB-8F4A18F6E287 Q35914452-8DC0FF6D-D93B-45BF-A120-889F38420447 Q36106408-C1026735-A2CD-490A-8C7F-007A2B298850 Q36147475-2BA910A5-2E43-432F-A2A7-ECB448C3F60E Q36148959-F7658280-34ED-46D5-AF05-587CABBF6444 Q36401352-D4174AEE-C7E7-4188-BDC7-79B8EF3D954A Q36545533-AB6B12D0-27BC-44C4-9390-F0FFC5CA2316 Q36652351-2009F60E-124D-4640-9FE8-33616714B080 Q36673382-D9C9B378-82BE-46B2-ABEF-3EB23F829E3C Q36685842-90C35EBA-A871-41BE-A8AC-EEF9B431EBDA Q36708296-6FB69997-296D-4B1A-BFCB-6019D397F28B Q37066228-8159A0B3-6D88-48BB-9B07-CB0B33688A06 Q37140657-677B9338-937E-4BE9-B09C-E06B92C5F133 Q37148191-C07966EC-C30C-44F2-87C0-D2F53D74772E Q37348229-BC31CF5B-64EE-4752-B1AB-68A985F7CA77 Q37356520-6002E311-7B5B-4BC9-B207-D2BCDAB8A1F0 Q37395618-C0CEC868-2AC4-422B-B611-09670469BDBA Q37396408-ED2AF43A-6789-4555-8F6E-528F3AA546F7 Q37479802-077E6052-8D89-42BC-9CED-8DE3B2D69A62 Q37589614-E82445D5-ADEF-4B90-B255-B5F11B5ECFBA Q37687423-8E571DE8-B2AE-4C21-AC51-33D0E0FF3C73 Q37773267-B89B1652-B561-4B16-BB3C-2389C5F5AA57 Q38592185-FB2A38C9-EDBA-4F1E-A44B-964D08C2D3F6 Q38901858-096797FA-9966-4238-8A94-87665D0FBE99 Q38934765-84898FB2-9CBE-4396-B040-E8C9851A2CBE Q39501488-8188CC2D-3C29-42E7-AFCB-5507B3052350 Q39860625-66C4B514-5303-4865-8396-484C3B7B37DB

P2860

Treatment of human disease by adeno-associated viral gene transfer.

http://www.wikidata.org/entity/Q36448393

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Treatment of human disease by adeno-associated viral gene transfer.

@ast

Treatment of human disease by adeno-associated viral gene transfer.

@en

type

label

Treatment of human disease by adeno-associated viral gene transfer.

@ast

Treatment of human disease by adeno-associated viral gene transfer.

@en

prefLabel

Treatment of human disease by adeno-associated viral gene transfer.

@ast

Treatment of human disease by adeno-associated viral gene transfer.

@en

P1433

Q36448393-87745879-241A-4659-87AA-B37F8D64D53B

P1476

Q36448393-B095A025-2D8B-43BC-B937-89A839689688

P2093

Q36448393-46B925B0-7C42-43D3-B446-645BF651CD35

Q36448393-FDA599BA-0F12-4EDE-A7B0-B4F7F1D0AAC6

P2860

Q36448393-135E9E8D-700C-4AF7-84AB-EA1F5692C1D2

Q36448393-15C05D87-6265-4D22-92E5-7AB5DAB61F7A

Q36448393-20102590-55D6-4964-8211-15ED68296876

Q36448393-3E7F01F2-C1E2-4602-8B5D-7460821F9B1F

Q36448393-465AEB88-0B38-4B9B-B6BA-0B81C8BB7A69

Q36448393-6D28B0DA-20BA-489B-A082-F797F4930FF8

Q36448393-7412E6C1-2014-45E3-B5C9-52FCFFBD0A05

Q36448393-CCD71E1D-A8C2-4D71-A095-5839A017A20A

Q36448393-D1F2A1E5-5031-4520-840D-3763F41E2A7D

Q36448393-FF8C0772-288E-40FA-A01C-959CC4919D4D

P2888

Q36448393-88F87A4E-B46A-4CDC-97BE-0DCE1F99C969

P304

Q36448393-46A19F4D-E0EF-4EB1-B813-CA4A74881FF2

P31

Q36448393-2FB20F1D-D709-46A0-A659-E315DD086DA6

P356

Q36448393-3C83E498-B5B1-4086-BB85-002E154A44BF

P433

Q36448393-255530F3-5C4E-42FE-9DC5-C99A8DE35A3E

P478

Q36448393-BB1AA382-8EA8-4E02-8E53-0AC30DF7181F

P577

Q36448393-EE295EFB-9B21-4792-BEA2-20BC33CED089

P698

Q36448393-04E6F833-1B68-4CA5-970F-C06720EC0979

P356

S00439-006-0165-6

P1433

P1476

Treatment of human disease by adeno-associated viral gene transfer.

@en

P2093

Kenneth H Warrington

http://www.w3.org/2001/XMLSchema#string

Roland W Herzog

http://www.w3.org/2001/XMLSchema#string

P2860

Function and genetics of dystrophin and dystrophin-related proteins in muscle.

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.

Inhibitory effect of adeno-associated virus-mediated gene transfer of human endostatin on hepatocellular carcinoma

Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo.

Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency.

Antitumor effect of an adeno-associated virus vector containing the human interferon-beta gene on experimental intracranial human glioma.

Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).

Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration.

Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.

Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes.

P2888

s00439-006-0165-6

P304

571-603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00439-006-0165-6

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16612615

http://www.w3.org/2001/XMLSchema#string